EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, TMC Life Sciences Bhd's enterprise value is RM1,277.4 Mil.
TMC Life Sciences Bhd's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was RM101.2 Mil. Therefore, TMC Life Sciences Bhd's EV-to-EBITDA for today is 12.62.
The historical rank and industry rank for TMC Life Sciences Bhd's EV-to-EBITDA or its related term are showing as below:
XKLS:0101'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -12.22 Med: 27.53 Max: 81.09
Current: 12.62
During the past 13 years, the highest EV-to-EBITDA of TMC Life Sciences Bhd was 81.09. The lowest was -12.22. And the median was 27.53.
XKLS:0101's EV-to-EBITDA is ranked better than 52.06% of 461
companies
in the Healthcare Providers & Services industry
Industry Median: 12.95
vs XKLS:0101: 12.62
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
TMC Life Sciences Bhd EV-to-EBITDA Historical Data
The historical data trend for TMC Life Sciences Bhd's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of TMC Life Sciences Bhd's EV-to-EBITDA
For the Medical Care Facilities subindustry, TMC Life Sciences Bhd's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TMC Life Sciences Bhd's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, TMC Life Sciences Bhd's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where TMC Life Sciences Bhd's EV-to-EBITDA falls into.
TMC Life Sciences Bhd's current Enterprise Value is RM1,277.4 Mil.
TMC Life Sciences Bhd's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was RM101.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TMC Life Sciences Bhd (XKLS:0101) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
TMC Life Sciences Bhd's PE Ratio for today is calculated as:
TMC Life Sciences Bhd's share price for today is RM0.72.
TMC Life Sciences Bhd's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.033.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of TMC Life Sciences Bhd's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
TMC Life Sciences Bhd (XKLS:0101) Business Description
TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKLS:0101 has been successfully added to your 